News

Avid Bioservices, Inc. and Humanigen, Inc. announced that they have entered into a manufacturing services agreement to expand production capacity for lenzilumab™, Humanigen’s therapeutic candidate in development for COVID-19. Lenzilumab is an anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal...

Novartis announced that asciminib, a novel investigational treatment specifically targeting the ABL myristoyl pocket (STAMP), has been granted Breakthrough Therapy designation (BTD) by the US FDA for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+...

Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath COVID–19 HT Kit that is compatible with the Amplitude platform. The high-throughput solution enables clinical and public health laboratories to efficiently test up...

Union health minister Harsh Vardhan has said that the country is developing seven more Covid-19 vaccines to make them available to every citizen of India. “We are currently administering the Covishield and Covaxin vaccines to healthcare and frontline workers. The...

China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public. This is the second vaccine approved by China’s National Medical Products Administration (NMPA). Both of the vaccines, along with another experimental vaccine from Sinopharm, have...

Merck and BioNTech have announced a further expansion of their strategic partnership to accelerate the supply of urgently needed lipids and boost the amount of their delivery by the year-end. The lipids will be used for producing the Pfizer and...

TIACA and Pharma.Aero jointly release their second report for the global air cargo and pharmaceutical industries outlining recommended practices and insights for effective COVID-19 vaccine air transportation and handling. The report reinforces that COVID-19 vaccines are of high value and...